# Stratifying Risk for Intracerebral Haemorrhage

> **NCT04140812** · NA · UNKNOWN · sponsor: **University of Erlangen-Nürnberg Medical School** · enrollment: 50 (estimated)

## Conditions studied

- Preterm Birth
- Coagulation Protein Disorders
- Coagulation Disorder Neonatal

## Interventions

- **DIAGNOSTIC_TEST:** mass spectrometry (LC-MS/MS)

## Key facts

- **NCT ID:** NCT04140812
- **Lead sponsor:** University of Erlangen-Nürnberg Medical School
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-10-21
- **Primary completion:** 2020-09-30
- **Final completion:** 2020-09-30
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2019-10-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04140812

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04140812, "Stratifying Risk for Intracerebral Haemorrhage". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04140812. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*